chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Assessed to have a rash-patchy red-slightly swollen areas to trunk and upper, lower extremities, (more to trunk). Lasted only one day. (One day after administration of vaccine).
Information has been received from a female with a history of shingles who on approximately 29-MAR-2007 was vaccinated with Zostavax (Merck). Concomitant therapy included Famvir. On 17-APR-2007 the patient experienced shingles again. The patient's shingles persisted. Additional information has been requested.
mom reported child lt deltoid to elbow is swollen, red, warm & tender to touch;day p/vax 9MAR99 mom states is RN & the arm seems to be getting worse, no resp distress just a bad localized rxn;
low grade fever; This case was reported by a other health professional via other manufacturer and described the occurrence of low grade fever in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included heart rate increased and hyperactivity. Concurrent medical conditions included pain (being in pain all her life and was being followed by pain management) and rheumatoid arthritis. Concomitant products included tofacitinib citrate (Xeljanz Xr).   On 17th March 2021, the patient received the 2nd dose of Shingles vaccine. In March 2021, less than a week after receiving Shingles vaccine, the patient experienced low grade fever. On an unknown date, the outcome of the low grade fever was unknown.   It was unknown if the reporter considered the low grade fever to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was a clinician. The age at vaccination was not reported.  The patient prior to start of therapy having increase heart rate, and thought it was related to her being hyperactive (patient did not clarify hyperactive) and it was unknown if the physician was aware of it. The patient received 2nd dose of Shingrix and experienced low-grade fever and the physician was not aware of it. No further information was reported.
Aching in knees; joints aching; pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Aching in knees), ARTHRALGIA (joints aching), PAIN (pain) and FATIGUE (fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced ARTHRALGIA (Aching in knees), ARTHRALGIA (joints aching), PAIN (pain) and FATIGUE (fatigue). At the time of the report, ARTHRALGIA (Aching in knees), ARTHRALGIA (joints aching), PAIN (pain) and FATIGUE (fatigue) outcome was unknown.            Concomitant medications were not reported. Treatment information was not reported.
10-10-08 patient called- reported  numb/tingle left thumb. Left arm throbbing. 10-13-08 office visit - pain left arm decreased range of motion in left shoulder
Git 1 injection June 1. No side effects at all. June 29, got 2nd injection and everything went to hell! I've never had so much pain in my  life, and I e had 3 major surgeries! Woke up July 1,the next morning with low grade fever,cold sweats, aching hamstrings, aching guads,all joints feel inflamed, headache,stomach, Feet and hand were tingling very very bad! Could not sleep because pain excruciating! By Thursday morning, I could not walk. Walking caused  more pain. I was able to walt in pain by Saturday afternoon. Sunday morning I wet to the Dr.  He put me on prednisone.  Did not help. Pain was so intense could barely walk.  Went to  dr on Wednesday.  Prescribed higher doses of prednisone and gabapentin.  Still have numbness in feet and hands. All joints are still inflamed.  Just now being able to walk, but I have to walk in an awkward position.  Dr did a full blood panel test. Everything came back normal except for low vitamin d.how long will this last??????.?
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 02-MAR-2010, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 17-JUN-2016, the patient was treated by a physician, for the onset of a vesicular rash, which was diagnosed as herpes zoster. On or about 02-AUG-2016, the patient sought subsequent treatment from the physician for ongoing and worsening symptoms of shingles and pain, which was diagnosed as post-herpetic neuralgia, a chronic condition of pain and nerve damage secondary to herpes zoster infections.  The patient has been prescribed gabapentin, LYRICA, nortriptyline, and OXYCONTIN for management of her painful symptoms and excruciating pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
MMR Adm 7/7/06. Body ache on 7/15/06 then followed by swollen glands and increased body aches on 7/18/06. Neck glands swollen with chills, temp increase, has not taken, Pt seen at med 7/19/06.
Pt started symptoms late night of 9th easy later fever, chills, shaky, swelling of the lips and the site of injection/vaccine, blisters in the mouth, diarrhea, abd. pain, headache, fatigue, arthralgia, anorexia, rash nose, lips, drowsiness. ZYRTEC and VALTREX given.
Vertigo (worsened); Dizziness (worsened); Emesis (worsened); Fatigue (worsened); Headache (worsened); This case was reported by a consumer via call center representative and described the occurrence of vertigo in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd January 2023, the patient received the 2nd dose of Shingrix. On 24th January 2023, 2 days after receiving Shingrix, the patient experienced vertigo, dizziness, vomiting, fatigue and headache. On an unknown date, the outcome of the vertigo, dizziness, vomiting, fatigue and headache were not recovered/not resolved.   It was unknown if the reporter considered the vertigo, dizziness, vomiting, fatigue and headache to be related to Shingrix.     Additional Information: GSK Receipt Date: 24-JAN-2023 Reporter's comments: The caller was the patient who had reported that, she had received dose of Shingrix in the left arm. The patient had experienced vertigo, emesis, fatigue, headache, and dizziness. The patient reported that, all the symptoms had begun this morning at the time of reporting and have gotten worse since they had begun.  The reporter had consent to follow-up.
STATES AFTER INJECTION FELT SOME TINGLING IN FINGERS IN BOTH  HANDS NO OTHER SYMPTOMS OBERVED FOR 30 MINUTES DISCHARGED DENIES ANY COMPLAINTS
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A physician reported that a male patient, his grandson, received the second dose of PREVNAR 7, on an unspecified date via unknown route of administration. Additional suspect medication, HIB vaccine, was received via unknown route of administration on the same unknown date. The patient was 4 months old at the time. Concomitant medications were not reported. Relevant medical history includes a fever following the first dose of PREVNAR. The patient experienced a fever to 102 and irritability for 24 hours. The seriousness criteria for these events were none. The outcome of the events at the time of the report was recovered.
Initial information received from a consumer on 12 November 2013. The reporter who is the patient's parent also reported another event which is captured in case # 2013SA117464. A male patient in his 20's was vaccinated in 1989 with a Td vaccine (manufacturer, lot number, route and site not reported). The patient turned white and passed out 10 - 15 minutes after vaccination. The patient's medical history and concomitant medications were not reported. Treatment details were not reported. The patient recovered on an unreported date. Further details were not available at the time of this report. Documents held by sender: None.
Pt complained of dizziness, diaphoresis, pallor; felt feverish, hot to touch. Pulse Ox ITR stable. Mild hypotension 70/50. Recovered to 100-110/70 at time of discharge.
pt recv vax; w/ 2nd dose, devel prominent cervical & periauricular lymphadenopathy w/ poss inguinal lymphadenopathy;CBC & cultures neg; recovered;
Penis doesn't go up anymore; gets big but does not get hard; he has not been able to stand or use his legs.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administration date 26May2021 (Lot number: EW0179) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1 , Lot Number: EW0179, NDC and Expiry Date: Unknown by the caller), administration date: 05May2021, when the patient was 44 years old, for Covid-19 Immunization. The following information was reported: PENIS DISORDER (non-serious), outcome "unknown", described as "Penis doesn't go up anymore; gets big but does not get hard"; DYSSTASIA (non-serious), outcome "unknown", described as "he has not been able to stand or use his legs.".  Additional information: Is report related to a study or programme- No. The patient wants to know what he can do about this.  No follow-up attempts are possible. No further information is expected.
FOOT PAIN; SWELLING OF RIGHT ANKLE; FEVER; NAUSEA; PAIN ON THE ARM; This spontaneous report received from a patient concerned a 50 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, non smoker, and non alcohol user, and other pre-existing medical conditions included the patient had no known allergies. the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered in left arm on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2021, the subject experienced fever. On 03-APR-2021, the subject experienced nausea. On 03-APR-2021, the subject experienced pain on the arm. On 04-APR-2021, the subject experienced swelling of right ankle. On an unspecified date, the subject experienced foot pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, nausea, and pain on the arm on 04-APR-2021, and the outcome of swelling of right ankle and foot pain was not reported. This report was non-serious.
Swelling under the armpit; very hot; couldn't put an arm down for days; very hot couldn't put an arm down for days still swollen to this day with pain.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Oct2021 (Lot number: 30155BA) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Swelling under the armpit"; FEELING HOT (non-serious) with onset 02Oct2021, outcome "not recovered", described as "very hot"; MOBILITY DECREASED (non-serious) with onset 02Oct2021, outcome "not recovered", described as "couldn't put an arm down for days"; PAIN IN EXTREMITY (non-serious) with onset 02Oct2021, outcome "not recovered", described as "very hot couldn't put an arm down for days still swollen to this day with pain.". Therapeutic measures were not taken as a result of lymphadenopathy, feeling hot, mobility decreased, pain in extremity.  Additional Information: Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine was No. List of any other medications the patient received within 2 weeks of vaccination was No. Reported Event Swelling under the armpit after A hour getting vaccinated ,very hot couldn't put an arm down for days still swollen to this day with pain. Prior to vaccination, was the patient diagnosed with COVID-19 was Unknown. Since the vaccination, has the patient been tested for COVID-19 was No. No Known allergies.  Follow-up attempts are completed. No further information is expected. .
Patient was diagnosed with Hodgkin's lymphoma in Dec 2021...lymphadenopathy was on L mediastinum and L supraclavicular areas
Rash appeared 8 days after vaccination and grew in size and itchiness for a few days before slowly fading away 2-3 weeks later.
No major systemic symptoms; minor, unilateral, ipsilateral, supraclavicular lymphadenopathy; single,  mobile, slightly tender, not hard or fixed; approximately a cm; more medial and somewhat more proximal (roughly parasternal line)
Fever, chills, shivering, headache, muscle tightness, muscle ache all lasting for about 12 hours the first time and 3 more days following, each day lessening in severity and duration.
During the routine visit on 3/7/03 she reportedly experience fever and weakness in both legs for 2 months.  Pt had no explanation why she didn't contact me.  That resolved since.  On 3/7/03 initiated tx for depression with somatic components.
8/2/03 irritable and up all night. 8/25 Fever 103, emesis. Diagnosed with otitis and treated with Augmentin. 8/28 Afebrile, rash all over, still irritable. 9/5 still and PO irritability, ? headache, unstable gait, ER visit. 9/7 increased instability, emesis; admitted to hospital. CT of head, LP, ataxia. Discharged home 9/9/03. All better by 9/12.
HPV vaccine administered in Right arm. Then meningitis administered in left arm. As soon as second vaccine given patient stated she could not see. Patient then started to pass out and I laid her down on table. Patient had seizure-like tremor one time. Doctor evaluated patient and within five minutes she felt better. After approx. 30 more minutes patient left the office feeling better.
Per patient, she was not diagnosed with rheumatoid arthritis until after 2 doses of moderna covid-19 vaccine and believes that the vaccine triggered the immune reaction
I had shot and still got shingles/ Suspected vaccination failure; Got shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was self-reported by the patient. The age at vaccination was not reported. The reporter stated that, he/she had the shot and still got shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
This case was reported by a lawyer and described the occurrence of pain, swelling and burning of the joints in a female subject of unspecified age who was vaccinated with Lyme disease vaccine recombinant Lymerix, for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Lymerix (unknown). On an unspecified date after vaccination with Lymerix, the subject experienced pain, swelling and burning in her joints, fatigue, flu like symptoms, coordination and balance problems, asthma, allergies, cognitive problems, sleep disturbances, gastrointestinal problems, hypothyroidism, possible neurological injuries, possible autoimmune disease and decreased activities of daily life. This case was assesses as medically serious by manufacturer (OMIC). At the time of reporting the outcome of the events was unspecified. This information was received via a statement of injuries.
A non-serious spontaneous report of fever, fatigue, nasal congestion, and sneezing has been received from a nurse concerning a 20-year-old female patient subsequent to FLUMIST.  No past medical history nor concomitant medications were reported.  The patient received FLUMIST on 14-Jan-2009 for the first time.  Within 48 hours after receiving FLUMIST, the patient developed a fever, fatigue, nasal congestion, and sneezing.  The patient did not recall being in close proximity to anyone with similar symptoms during the week prior to onset of the symptoms.  The patient  recovered from the events on 22-Jan-2009.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with VARIVAX injection (subcutaneously; dose, lot# and expiration date were not provided). On an unknown date,the patient developed chickenpox, despite that she was vaccinated with VARIVAX when she was younger. It was unknown if the patient received any treatment or had lab diagnostic studies performed. The outcome of vaccination failure and chickenpox was not provided. The relatedness between adverse events and VARIVAX was not provided. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA011849:
First day after, I had mild symptoms - tired; I felt feverish at time even though I didn't have a fever. On the 23rd, I felt a little better that day but on the 24th, I really didn't feel well that day. I was tired and kind of slightly nauseated; not really wanting to eat but tried. I was so nauseated that night and had a headache. I wished I could have vomited that night. If I tried to move my head the pain was just terrible. 25th - called my COVID nurse line at work. She took me to get a COVID test and stayed with my mom that  night. I had nausea and fevers that night - up to 101. Headache was absolutely horrible. The COVID test was negative. 26th -severe  headache, nauseated, fever. I didn't feel great on the 28th but I did return to work that day. Lymph nodes on my neck were swollen - could see them across the room. Those were swollen on Sunday, Monday and Tuesday and started to get better on Wednesday. I would take a 1/2 of Benadryl and that would allow me to rest for about 2 1/2 hours. On 25th - I woke up soaked when I woke up because I had such better sweating. The night of the 24th at 09:00 to midday Tuesday - that was pretty bad. I was breastfeeding at this time so didn't want to take too much to treat.
bleeding nose; Fever; Low energy; Vomiting; diareah; a runny nose this morning from my left nostril; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diareah), EPISTAXIS (bleeding nose), RHINORRHOEA (a runny nose this morning from my left nostril), PYREXIA (Fever) and FATIGUE (Low energy) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD, Drug allergy (Percodan), Vegetable allergy (Tomatoes) and Fruit allergy (Strawberries). Concomitant products included PARACETAMOL (TYLENOL), ALPRAZOLAM, LAMOTRIGINE, METOPROLOL SUCCINATE (TOPROL XL), PREDNISONE, SIMVASTATIN, TRAMADOL, VENLAFAXINE HYDROCHLORIDE (EFFEXOR), ZOLPIDEM TARTRATE (AMBIEN) and TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced RHINORRHOEA (a runny nose this morning from my left nostril). On 24-May-2021, the patient experienced DIARRHOEA (diareah), PYREXIA (Fever), FATIGUE (Low energy) and VOMITING (Vomiting). On an unknown date, the patient experienced EPISTAXIS (bleeding nose). At the time of the report, DIARRHOEA (diareah), PYREXIA (Fever), FATIGUE (Low energy) and VOMITING (Vomiting) had not resolved, EPISTAXIS (bleeding nose) outcome was unknown and RHINORRHOEA (a runny nose this morning from my left nostril) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    In treatment details patient reported that she tilted her head up and used ice in order to stop the bleeding nose. She reported that she has not took any medications to help with the symptoms.   This case was linked to MOD-2021-223818 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Added medical history, allergies, facility information and events. Updated patient demographics.
Patient sitting in chair. Tried to get up. Syncope. Patient wife with him, sat him back in chair called for me. Pt was concious when I got to him. Said he was ok. Asked him to remain sitting for 30 min. Watched him. After 30 minutes, he said he was Ok.
This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On an unknown date, the patient was vaccinated with LIQUID PEDVAXHIB (strength, dose and route were not reported) (lot # R000877 and expiration date: 24-SEP-2020) for prophylaxis (product storage error). The vaccine was stored in below 32 degrees Fahrenheit (F) / 0 degree Celsius (C) (-0.3 C) for 64 hours. The digital data logger was not involved in recording the temperature excursion. No adverse effects were reported. There was no product quality complaint (PQC) reported. This is one of the several reports received from same reporter. Sender's Comments: US-009507513-1806USA012211: US-009507513-1806USA012212: US-009507513-1806USA011719.
Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Additional Details: Called paramedics Patient taken to hospital--was told it was vagal response to vaccination
So far there are no adverse effects, however, I mistakenly administered the Pfizer Bivalent 12+ dose to this 9 year old patient today at an offsite flu/covid clinic at her school.  We realized an error had been made when we returned to the store to scan the consent forms and the computer system would not allow us to add the Pfizer Bivalent Booster 12+ because the patient is not at least 12 years old.  Father of the patient was contacted this evening around 10:00 p.m.